Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris [Phase 4]
Phase 4 clinical trial comparing tazarotene plus clindamycin to adapalene plus clindamycin for facial acne vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: A Long Term Study of GK530G in Subjects With Acne Vulgaris [Phase 3]
A long-term Phase 3 study of GK530G in acne vulgaris has completed and results were posted in January 2017.
-
FDA approval · 2016-12-23FDA Approved: TRETINOIN — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's generic tretinoin under an Original Application, broadening access to tretinoin products.
-
CLINICAL_TRIALS trial_result · 2016-12-20Clinical Trial Update: Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris [Phase 3]
A Phase 3 trial evaluating dapsone 5% gel for acne vulgaris has completed.
-
CLINICAL_TRIALS withdrawal · 2016-12-06Clinical Trial Update: A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris [Phase 4]
Phase 4 clinical trial evaluating a Pulse Dye Laser (Chromogenex Regenlite Transform) for inflammatory acne vulgaris has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris. [Phase 3]
Phase 3 study comparing GK530G gel with CD0271 0.1% gel and CD1579 2.5% gel for acne vulgaris; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris [Phase 3]
This document provides an update on a Phase 3 trial evaluating generic tazarotene cream 0.1% for acne vulgaris, which has completed the stud…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris. [Phase 2]
Phase 2 trial comparing two concentrations of CD1579 gel to vehicle for acne vulgaris, assessing efficacy and safety with results posted aft…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Psychiatric Problems in Chronic Skin Diseases
A clinical trial examining psychiatric problems in chronic skin diseases has completed, with the study covering psoriasis, acne vulgaris, vi…
-
FDA approval · 2016-10-18FDA Approved: DOXYCYCLINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves a supplemental application for doxycycline from Lupin Pharmaceuticals, Inc. to modify/expand an existing generic product approv…
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Non-cutting Laser Therapy in the Treatment of Acne [Phase 2]
A Phase 2 clinical trial evaluating non-cutting laser therapy for acne vulgaris has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use [NA]
The study completion update describes a pragmatic, clinic-focused trial of MedlinePlus Health Prescriptions sponsored by the University of M…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris [Phase 3]
Phase 3 multicenter, randomized, double-blind trial evaluating the efficacy and safety of CD0271 0.3%/CD1579 2.5% topical gel in acne vulgar…
-
FDA approval · 2016-09-01FDA Approved: CLINDAMYCIN PHOSPHATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for clindamycin phosphate by Sun Pharmaceutical Industries, Inc. This is for a generic antibiotic pr…
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris [Phase 2]
A Phase 2 clinical trial evaluating CTX-4430 for moderate to severe facial acne vulgaris has completed.
-
FDA approval · 2016-07-08FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for ZENATANE (isotretinoin) from BluePoint Laboratories.
-
FDA approval · 2016-07-08FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Claravis (isotretinoin) by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2016-07-08FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental Abbreviated New Drug Application for AMNESTEEM, a generic isotretinoin product from Mylan Pharmaceuticals.
-
FDA approval · 2016-07-08FDA Approved: DIFFERIN — Supplemental Application (Galderma Laboratories, L.P.)
The FDA approved a supplemental application for DIFFERIN (adapalene) submitted by Galderma Laboratories, L.P.
-
FDA approval · 2016-07-08FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)
FDA approved a supplemental application for isotretinoin from Mayne Pharma.
-
FDA approval · 2016-07-08FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for CLARAVIS (isotretinoin) filed by Teva Pharmaceuticals USA, Inc. The action pertains to changes t…
-
FDA approval · 2016-07-08FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ABSORICA (isotretinoin) from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2016-06-23FDA Approved: ADAPALENE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a generic Adapalene product under an Original Approval Application, with Sun Pharmaceutical Industries listed as the manufactur…
-
CLINICAL_TRIALS trial_result · 2016-06-16Clinical Trial Update: A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris [Phase 2]
A Phase 2 clinical trial assessing the efficacy of topically applied MTC896 Gel for acne vulgaris; current study status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris [Phase 4]
Phase 4 clinical trial update for a treatment regimen in acne vulgaris completed with posted results.